Masimo (MASI)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$179.950.00%
Close 2026-06-10 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · MASI
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| FY 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenues | 1,526.9 | 1,526.9 | 2,094.4 | 1,275.5 | 1,239.2 | 1,143.7 | — | 937.8 | 858.3 | 790.2 | 712.9 | 630.1 | 586.6 | 547.2 | 493.2 | 439.0 | 405.4 |
| Total Revenues | — | — | — | — | 1,239.2 | 1,143.7 | — | 937.8 | 858.3 | 790.2 | 712.9 | 630.1 | 586.6 | 547.2 | 493.2 | 439.0 | 405.4 |
| Cost of Revenues | 581.7 | 581.7 | 1,090.0 | 509.9 | 977.0 | 400.7 | — | 308.7 | 283.4 | — | — | — | — | — | — | — | — |
| Gross Profit | 945.2 | 945.2 | 1,004.4 | 765.6 | 1,058.8 | 743.0 | — | 629.2 | 574.9 | 522.0 | 478.3 | 410.0 | 390.8 | 358.8 | 326.3 | 294.1 | 285.6 |
| Operating Expenses & Income | |||||||||||||||||
| Selling, General & Admin | 506.0 | 506.0 | 743.8 | 451.3 | 657.4 | 369.0 | — | 314.7 | 285.4 | 273.0 | 254.7 | 252.7 | 241.0 | 215.5 | 193.9 | 169.2 | 174.1 |
| R&D Expenses | 126.4 | 126.4 | 222.8 | 130.5 | 191.4 | 118.7 | — | 93.3 | 81.0 | 65.2 | 57.7 | 56.6 | 56.6 | 55.6 | 47.1 | 38.4 | 36.0 |
| Operating Income | 310.0 | 310.0 | (266.7) | 166.0 | 210.0 | 255.8 | — | 221.2 | 208.0 | 183.8 | 435.9 | 120.3 | 103.5 | 79.7 | 85.2 | 86.5 | 106.2 |
| Earnings from Continuing Operations | |||||||||||||||||
| Interest Expense | — | 33.2 | 43.6 | 50.3 | 25.7 | 0.3 | — | 0.3 | 0.7 | — | — | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | (37.4) | (37.4) | (38.6) | (53.0) | (16.6) | 7.9 | — | 13.0 | 5.7 | 2.0 | (2.4) | (3.9) | (1.5) | (4.0) | (1.4) | 0.0 | 1.3 |
| Asset Writedown | — | — | 304.0 | 10.0 | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | 272.6 | 272.6 | (305.3) | 113.0 | 193.4 | 263.7 | — | 234.2 | 213.8 | 185.8 | 433.5 | 116.3 | 102.0 | 75.7 | 83.8 | 86.5 | 107.6 |
| Income Tax Expense | 64.9 | 64.9 | (0.4) | 5.3 | 49.9 | 23.4 | — | 38.0 | 20.2 | 61.0 | 122.4 | 34.8 | 27.7 | 20.0 | 21.9 | 22.5 | 34.2 |
| Net Income | |||||||||||||||||
| Minority Interest | — | — | — | — | — | (0.0) | — | — | — | 0.0 | 0.0 | (1.8) | 1.8 | (2.7) | (0.3) | 0.4 | (0.1) |
| Net Income | (151.5) | (151.5) | (304.9) | 81.5 | 143.5 | 240.3 | — | 196.2 | 124.8 | 124.8 | 311.1 | 83.3 | 72.5 | 58.4 | 62.3 | 63.7 | 73.5 |
| Per Share | |||||||||||||||||
| Basic EPS | (2.83) | (2.83) | (5.72) | 1.54 | 2.68 | 4.39 | — | 3.67 | 3.70 | 2.42 | 6.28 | 1.62 | 1.33 | 1.03 | 1.08 | 1.07 | 1.25 |
| Diluted EPS | (2.80) | (2.80) | (5.72) | 1.51 | 2.60 | 4.14 | — | 3.44 | 3.45 | 2.23 | 5.85 | 1.55 | 1.30 | 1.02 | 1.07 | 1.05 | 1.21 |
| Dividend per Share | — | — | — | — | — | — | — | — | — | — | — | — | 0.00 | 0.00 | 1.00 | 2.75 | 2.75 |
| Basic Weighted Avg Shares | 53.6 | 53.6 | 53.3 | 52.8 | 53.6 | 54.7 | — | 53.4 | 52.3 | 51.5 | 49.5 | 51.3 | 54.7 | 56.7 | 57.4 | 59.7 | 58.8 |
| Diluted Weighted Avg Shares | 54.2 | 54.2 | 53.3 | 54.1 | 55.2 | 58.0 | — | 57.1 | 56.0 | 55.9 | 53.2 | 53.7 | 55.6 | 57.5 | 58.4 | 60.8 | 60.6 |
| Supplemental | |||||||||||||||||
| EBITDA | 348.8 | 348.8 | (163.7) | 204.9 | 346.1 | 285.1 | — | 244.7 | 229.2 | 203.8 | 452.8 | 135.9 | 116.3 | 91.1 | 94.6 | 93.9 | 112.8 |
| EBIT | 310.0 | 310.0 | (266.7) | 166.0 | 210.0 | 255.8 | — | 221.2 | 208.0 | 183.8 | 435.9 | 120.3 | 103.5 | 79.7 | 85.2 | 86.5 | 106.2 |
| Effective Tax Rate | 23.8% | — | — | 4.7% | 25.8% | 8.9% | — | 16.2% | 9.5% | 32.8% | 28.2% | 29.9% | 27.1% | 26.4% | 26.1% | 26.0% | 31.8% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.